Sulfamerazine sodium saltCAS# 127-58-2 |
- Rocilinostat (ACY-1215)
Catalog No.:BCC2144
CAS No.:1316214-52-4
- LY 294002
Catalog No.:BCC3659
CAS No.:154447-36-6
- Doxorubicin
Catalog No.:BCC2082
CAS No.:23214-92-8
- E 64d
Catalog No.:BCC1127
CAS No.:88321-09-9
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 127-58-2 | SDF | Download SDF |
| PubChem ID | 15899899 | Appearance | Powder |
| Formula | C11H11N4NaO2S | M.Wt | 286.29 |
| Type of Compound | N/A | Storage | Desiccate at -20°C |
| Synonyms | Soluble sulfamerazine | ||
| Solubility | Soluble in DMSO | ||
| Chemical Name | sodium;(4-aminophenyl)sulfonyl-(4-methylpyrimidin-2-yl)azanide | ||
| SMILES | CC1=NC(=NC=C1)[N-]S(=O)(=O)C2=CC=C(C=C2)N.[Na+] | ||
| Standard InChIKey | BSFJGCCAXDCMOX-UHFFFAOYSA-N | ||
| Standard InChI | InChI=1S/C11H11N4O2S.Na/c1-8-6-7-13-11(14-8)15-18(16,17)10-4-2-9(12)3-5-10;/h2-7H,12H2,1H3;/q-1;+1 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | Sulfamerazine Sodium is a sulfonamide antibacterial.
Target: Antibacterial
Sulfamerazine, the monomethyl derivative of sulfadiazine, is 2-sulfanilamido-4-methylpyrimidine. Sulfamerazine is a sulfonamide drug that inhibits bacterial synthesis of dihydrofolic acid by competing with para-aminobenzoic acid (PABA) for binding to dihydropteroate synthetase (dihydrofolate synthetase). Sulfamerazine is bacteriostatic in nature. Inhibition of dihydrofolic acid synthesis decreases the synthesis of bacterial nucleotides and DNA [1]. References: | |||||
Sulfamerazine sodium salt Dilution Calculator
Sulfamerazine sodium salt Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 3.493 mL | 17.4648 mL | 34.9296 mL | 69.8592 mL | 87.324 mL |
| 5 mM | 0.6986 mL | 3.493 mL | 6.9859 mL | 13.9718 mL | 17.4648 mL |
| 10 mM | 0.3493 mL | 1.7465 mL | 3.493 mL | 6.9859 mL | 8.7324 mL |
| 50 mM | 0.0699 mL | 0.3493 mL | 0.6986 mL | 1.3972 mL | 1.7465 mL |
| 100 mM | 0.0349 mL | 0.1746 mL | 0.3493 mL | 0.6986 mL | 0.8732 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
Sulfamerazine Sodium is a sulfonamide antibacterial.
- Sulfacetamide Sodium
Catalog No.:BCC4383
CAS No.:127-56-0
- 2,2-Bis(4-hydroxy-3-isopropylphenyl)propane
Catalog No.:BCC8494
CAS No.:127-54-8
- Vitamin A Acetate
Catalog No.:BCC4748
CAS No.:127-47-9
- Lutein
Catalog No.:BCN6151
CAS No.:127-40-2
- Lasiocarpine N-oxide
Catalog No.:BCN2002
CAS No.:127-30-0
- Pimaric acid
Catalog No.:BCN6149
CAS No.:127-27-5
- Taraxerol
Catalog No.:BCN6148
CAS No.:127-22-0
- Sodium acetate
Catalog No.:BCC7587
CAS No.:127-09-3
- Hydroxyurea
Catalog No.:BCC4912
CAS No.:127-07-1
- Locustatachykinin I
Catalog No.:BCC5926
CAS No.:126985-97-5
- 1-(3,4-Dihydroxyphenyl)-7-(4-hydroxyphenyl)heptane-3,5-diyl diacetate
Catalog No.:BCN6572
CAS No.:1269839-26-0
- 5-Hydroxy-1,7-bis(4-hydroxyphenyl)heptan-3-yl acetate
Catalog No.:BCN6586
CAS No.:1269839-24-8
- Sulfisoxazole
Catalog No.:BCC4860
CAS No.:127-69-5
- Sulfamerazine
Catalog No.:BCC4854
CAS No.:127-79-7
- Beta-Pinene
Catalog No.:BCC8302
CAS No.:127-91-3
- 4,9-Dimethoxycanthin-6-one
Catalog No.:BCN3107
CAS No.:1270001-72-3
- CGP 42112
Catalog No.:BCC5921
CAS No.:127060-75-7
- Sulfo-NHS-LC-Biotin
Catalog No.:BCC3578
CAS No.:127062-22-0
- Glyceryl hexacosanoate
Catalog No.:BCC8991
CAS No.:127098-14-0
- BMS-911543
Catalog No.:BCC2204
CAS No.:1271022-90-2
- MI-3
Catalog No.:BCC1747
CAS No.:1271738-59-0
- MI-2
Catalog No.:BCC1746
CAS No.:1271738-62-5
- 4-O-Demethylkadsurenin D
Catalog No.:BCN6649
CAS No.:127179-70-8
- 7-(2'-Deoxyadenosin-N6-yl)aristolactam I
Catalog No.:BCN2559
CAS No.:127191-86-0
Structural, Mechanical, and Transport Properties of Electron Beam-Irradiated Chitosan Membranes at Different Doses.[Pubmed:30966153]
Polymers (Basel). 2018 Jan 26;10(2). pii: polym10020117.
Chitosan powder irradiated by electron beam at different doses, up to 250 kGy, was used to prepare membranes for drug release applications. The irradiation effect on the molecular weight of powder chitosan, the characteristics of the prepared membranes, and their transport of Sulfamerazine sodium salt (SULF) were investigated. The effect of the addition of glutaraldehyde (GLA) as a crosslinking agent in the chitosan solution used for the preparation of the membranes was also studied. A decrease in the chitosan molecular weight with the increase in the irradiation dose was observed, while the membranes prepared with the irradiated chitosan at higher dose exhibited lower swelling. However, an opposite behavior was detected when the membranes were prepared with GLA-crosslinked chitosan. A GLA crosslinking agent reduced the crystallinity of the chitosan membranes and the swelling, whereas the water contact angle and SULF transport increased with the increase in the irradiation dose.
Permeability studies in chitosan membranes. Effects of crosslinking and poly(ethylene oxide) addition.[Pubmed:16202398]
Carbohydr Res. 2005 Dec 12;340(17):2630-6.
Pure chitosan, glutaraldehyde crosslinked chitosan, and a blend of chitosan with poly(ethylene oxide) (PEO) membranes were prepared. The three membranes were characterized in terms of their swelling capacities as well as their permeabilities to a drug model (Sulfamerazine sodium salt). For the permeation experiments, the variables analyzed were the type of membrane and the initial drug concentration in the liquid phase (from 0.1% to 1.5%). Permeability coefficients were calculated using UV spectroscopy. The results showed that for the three analyzed membranes, the permeability did not change with time (over the studied time interval). An increase in the permeability for CHI/PEO membranes compared to those made of pure chitosan was also observed, possibly due to microporous region formation and/or crystallinity reduction. For the crosslinked membrane, an even higher increase in the permeability coefficient was observed. In this case, the increase was attributed to free volume variation.
